According to a new report, published by KBV research, The Global Endoscopy Fluid Management Market size is expected to reach $970 Million by 2028, rising at a market growth of 7.2% CAGR during the forecast period.
The Hysterroscopy segment is showcasing a CAGR of 7.6% during (2022 - 2028). The growth is attributed to its usage for investigating problems or symptoms like postmenopausal bleeding, pain in pelvic pain, difficulty getting pregnant or repeated miscarriages. Hysteroscopy assists in diagnosing conditions such as polyps and fibroids. Furthermore, it is also used to treat issues like intrauterine adhesions, polyps, or displaced intrauterine devices. The usage of hysteroscopy in conditions diagnosis and treatment will drive the growth of the segment.
The System segment acquired maximum revenue share in the Global Endoscopy Fluid Management Market by Product in 2021 thereby, achieving a market value of $655.8 Million by 2028. The growth is attributed to the advancements in technology in the healthcare sector. There is constant innovation for the product by numerous key companies to further enhance the products. Also, there is an increasing demand for these systems among users. The continuous enhancement of the product and the healthcare sector joined with the rising demand will surge the segment’s growth in the forecasted period.
The Clinics segment has shown the growth rate of 7.4% during (2022 - 2028). This is because of the increasing preference of patients to choose specialized centers for a particular treatment. Clinics can provide extra care to their patients due to their small size. In addition, many people get diagnosed by a clinic to get a fast report feedback. The benefits associated with the clinics are expected to boost the segment’s growth.
The North America market dominated the Global Endoscopy Fluid Management Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $349.5 Million by 2028. The Europe market is exhibiting a CAGR of 6.8% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 7.6% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/endoscopy-fluid-management-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Medtronic PLC, Olympus Corporation, Steris PLC, B. Braun Melsungen AG, Stryker Corporation, Hologic, Inc., ConMed Corporation, Karl Storz SE & Co. KG, Arthrex, Inc., and COMEG Medical Technologies (Acteon Group).
By Application
By Product
By End User
By Geography
Companies Profiled
Unique Offerings 
